TERAZOL®  7 VAGINAL CREAM 0.4% 
 (terconazole)   
 
TERAZOL®  3 VAGINAL CREAM 0.8% 
 (terconazole)   
 
TERAZOL®  3 VAGINA United States - English - NLM (National Library of Medicine)

terazol® 7 vaginal cream 0.4% (terconazole) terazol® 3 vaginal cream 0.8% (terconazole) terazol® 3 vagina

janssen pharmaceuticals, inc. - terconazole (unii: 0kj2ve664u) (terconazole - unii:0kj2ve664u) - terconazole 4 mg in 1 g - terazol® 7 (terconazole) vaginal cream 0.4%, terazol® 3 (terconazole) vaginal cream 0.8% and terazol® 3 (terconazole) vaginal suppositories 80 mg are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). as these products are effective only for vulvovaginitis caused by the genus candida, the diagnosis should be confirmed by koh smears and/or cultures. patients known to be hypersensitive to terconazole or to any of the components of the cream or suppositories.

TERAZOL 7 VAGINAL CREAM 0.4% Canada - English - Health Canada

terazol 7 vaginal cream 0.4%

janssen inc - terconazole - cream - 4mg - terconazole 4mg - azoles

TERAZOL 3 DUAL PAK OVULE Canada - English - Health Canada

terazol 3 dual pak ovule

janssen inc - terconazole; terconazole - ovule - 0.8%; 80mg - terconazole 0.8%; terconazole 80mg - azoles